filings.toolsItem 1A. RISK FACTORS
3K characters. Original on sec.gov · Markdown
Item 1A. RISK FACTORS
There have been no material changes to the risk factors disclosed in our annual report on Form 10-K for the year ended December 31, 2025.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
Issuer Purchases of Equity Securities
The following table discloses purchases of shares of our common stock made by us or on our behalf during the first quarter of 2026.
| Period | Total Number of Shares Purchased (a) | Average Price Paid per Share (b) | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs | Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs (c) | ||||||||||||||||||||||||||||
| January 2026 | 111,390 | $ | 191.83 | — | $1.7 billion | |||||||||||||||||||||||||||
| February 2026 | 45,258 | $ | 198.24 | — | $4.2 billion | |||||||||||||||||||||||||||
| March 2026 | 2,170,375 | $ | 243.28 | 2,168,555 | $3.7 billion | |||||||||||||||||||||||||||
| Total | 2,327,023 | $ | 239.94 | 2,168,555 | $3.7 billion |
(a)The shares reported in this column include 158,468 shares related to our purchases of shares from participants in our stock-based compensation plans in connection with the vesting of restricted stock and other stock compensation transactions in accordance with the terms of our stock-based compensation plans.
(b)The average price paid per share reported in this column excludes brokerage commissions and a one percent excise tax on share purchases.
(c)On October 29, 2024, we announced that our Board authorized us to purchase shares of our outstanding common stock for a total cost of up to $2.5 billion with no expiration date (the September 2024 Program). This authorization was granted on September 19, 2024. As of March 31, 2026, we had $1.2 billion remaining available for purchase under the September 2024 Program. On February 25, 2026, we announced that our Board authorized us to purchase shares of our outstanding common stock for a total cost of up to $2.5 billion with no expiration date, which is in addition to the amount remaining under the September 2024 Program.
Previous: Item 4. CONTROLS AND PROCEDURES · Next: Item 5. OTHER INFORMATION